المؤلفون: N Hamajima, K Hirose, K Tajima, T Rohan, CM Friedenreich, SM Gapstur, MM Gaudet, RJ Coates, JM Liff, E Kakouri, Y Marcou, SW Duffy, A Morabia, L Schuman, W Stewart, M Szklo, P Band, AJ Coldman, RP Gallagher, TG Hislop, P Yang, SR Cummings, J Hu, KC Johnson, Y Mao, P Chao, J Lissowska, K Canfell, PL Horn-Ross, LM Kolonel, AMY Nomura, T Bishop, D Palli, S De Sanjose, CA Gonzalez, N Lee, P Marchbanks, HW Ory, HB Peterson, P Wingo, K Ebeling, D Kunde, P Nishan, L Bergkvist, JL Hopper, F Sitas, S Franceschi, L Dal Maso, TH Chan, AH Eliassen, RM Tamimi, WC Willett, V Gajalakshmi, N Martin, T Pardthaisong, S Silpisornkosol, C Theetranont, B Boosiri, S Chutivongse, P Jimakorn, P Virutamasen, C Wongsrichanalai, A Neugut, R Santella, A Hadjisavvas, K Kyriacou, M Loizidou, CJ Baines, N Kreiger, AB Miller, C Wall, A Tjonneland T Jorgensen, C Stahlberg, A T0nnes Pedersen, E Negri, SE Hankinson, D Flesch-Janys, C La Vecchia, N Hakansson, I Heuch, HO Adami, E Weiderpass, A Ekbom, G Erlandsson, I Persson, C Magnusson, L Jones, K McPherson, A Neil, M Vessey, D Yeates, G Berry, J Cooper Booth, T Jelihovsky, R MacLennan, J Chang-Claude, R Kaaks, M Iwasaki, S Tsugane, GL Anderson, JR Daling, WB Hutchinson, CI Li, KE Malone, M Mandelson, PA Newcomb, EA Noonan, RM Ray, JL Stanford, MTC Tang, DB Thomas, NS Weiss, E White, A Izquierdo, P Viladiu, KM Egan, HR Cuevas, P Ontiveros, A Palet, SB Salazar, N Aristizabal, A Cuadros, L Tryggvadottir, EJ Olafsdottir, E Riboli, N Andrieu, A Bachelot, A Bremond, B Gairard, J Lansac, MG Le, L Piana, R Renaud, MC Boutron-Ruault, N Chabbert-Buffet, F Clavel-Chapelon, A Fournier, S Mesrine, F Levi, M Jones, AJ Swerdlow, A Wolk, K Kosmelj, M Primic-Zakelj, J Stare, G Torres-Mejia, I Romieu, P Boyle, F Lubin, B Modan, E Ron, Y Wax, M Ferraroni, E Marubini, EM Monninkhof, NC Onland-Moret, PHM Peeters, GD Friedman, RA Hiatt, M Touillaud, WL Beeson, G Fraser, J Peto, RL Hanson, MC Leske, MC Mahoney, PC Nasca, AO Varma, AL Weinstein, RA Goldbohm, PA van den Brandt, N Chantarakul, S Koetsawang, D Rachawat, MC Pike, M Gerber, S Richardson, C Segala, S Teitelbaum, D Gatei, P Kenya, A Kungu, JG Mati, LA Brinton, M Freedman, R Hoover, C Schairer, RG Ziegler, E Banks, R Spirtas, HP Lee, MA Rookus, FE van Leeuwen, JA Schoenberg, S Graff-Iversen, R Selmer, S Atkinson, I Barnes, V Beral, D Bull, T Gathani, A Goodill, J Green, C Hermon, T Key, K Pirie, G Reeves, K Shaw, TO Yang, R Collins, HC Pan, R Peto, R Ghiasvand, K Mabuchi, D Preston, SE McCann, P Hannaford, C Kay, JM Hampton, LJ Titus, A Trentham-Dietz, B Liu, YT Gao, F Jin, J-M Yuan, HY Wei, T Yun, C Zhiheng, PF Coogan, JR Palmer, L Rosenberg, EM John, Q-S Wang, M Kawai, Y Minami, I Tsuji, M Kumle, H Stalsberg, E Lund, EO Fourkala, I Jacobs, U Menon, A Ryan, L Hartman, H Olsson, K Katsouyanni, A Trichopoulou, A Tzonou, KA Baltzell, A Dabancens, L Martinez, R Molina, O Salas, L Rosero-Bixby, FE Alexander, K Anderson, AR Folsom, MD Gammon, BS Hulka, R Millikan, CED Chilvers, M McCredie, C Paul, DCG Skegg, GFS Spears, F Lumachi, TR Rebbeck, RA Apelo, J Baens, JR de la Cruz, B Javier, LB Lacaya, CA Ngelangel, J Cauley, for the Study of Osteoporotic Fractures, C Bain, F Schofield, V Siskind, L Bernstein, S Enger, RW Haile, A Paganini-Hill, G Ursin, AH Wu, MC Yu, M Ewertz, EA Clarke, XO Shu, W Zheng, M Gass, MJ O’Sullivan, A Kalache, TMM Farley, S Holck, O Meirik, A Fukao, X Zhou

المساهمون: RS: GROW - R1 - Prevention, RS: CAPHRI - R5 - Optimising Patient Care, Epidemiologie, N Hamajima, K Hirose, K Tajima, T Rohan, CM Friedenreich, SM Gapstur, MM Gaudet, RJ Coate, JM Liff, E Kakouri, Y Marcou, SW Duffy, A Morabia, L Schuman, W Stewart, M Szklo, P Band, AJ Coldman, RP Gallagher, TG Hislop, P Yang, SR Cumming, J Hu, KC Johnson, Y Mao, P Chao, J Lissowska, K Canfell, PL Horn-Ro, LM Kolonel, AMY Nomura, T Bishop, D Palli, S De Sanjose, CA Gonzalez, N Lee, P Marchbank, HW Ory, HB Peterson, P Wingo, K Ebeling, D Kunde, P Nishan, L Bergkvist, JL Hopper, F Sita, S Franceschi, L Dal Maso, TH Chan, AH Eliassen, RM Tamimi, WC Willett, V Gajalakshmi, N Martin, T Pardthaisong, S Silpisornkosol, C Theetranont, B Boosiri, S Chutivongse, P Jimakorn, P Virutamasen, C Wongsrichanalai, A Neugut, R Santella, A Hadjisavva, K Kyriacou, M Loizidou, CJ Baine, N Kreiger, AB Miller, C Wall, A Tjonneland T Jorgensen, C Stahlberg, A T0nnes Pedersen, E Negri, SE Hankinson, D Flesch-Jany, C La Vecchia, N Hakansson, I Heuch, HO Adami, E Weiderpa, A Ekbom, G Erlandsson, I Persson, C Magnusson, L Jone, K McPherson, A Neil, M Vessey, D Yeate, G Berry, J Cooper Booth, T Jelihovsky, R MacLennan, J Chang-Claude, R Kaak, M Iwasaki, S Tsugane, GL Anderson, JR Daling, WB Hutchinson, CI Li, KE Malone, M Mandelson, PA Newcomb, EA Noonan, RM Ray, JL Stanford, MTC Tang, DB Thoma, NS Wei, E White, A Izquierdo, P Viladiu, KM Egan, HR Cueva, P Ontivero, A Palet, SB Salazar, N Aristizabal, A Cuadro, L Tryggvadottir, EJ Olafsdottir, E Riboli, N Andrieu, A Bachelot, A Bremond, B Gairard, J Lansac, MG Le, L Piana, R Renaud, MC Boutron-Ruault, N Chabbert-Buffet, F Clavel-Chapelon, A Fournier, S Mesrine, F Levi, M Jone, AJ Swerdlow, A Wolk, K Kosmelj, M Primic-Zakelj, J Stare, G Torres-Mejia, I Romieu, P Boyle, F Lubin, B Modan, E Ron, Y Wax, M Ferraroni, E Marubini, EM Monninkhof, NC Onland-Moret, PHM Peeter, GD Friedman, RA Hiatt, M Touillaud, WL Beeson, G Fraser, J Peto, RL Hanson, MC Leske, MC Mahoney, PC Nasca, AO Varma, AL Weinstein, RA Goldbohm, PA van den Brandt, N Chantarakul, S Koetsawang, D Rachawat, MC Pike, M Gerber, S Richardson, C Segala, S Teitelbaum, D Gatei, P Kenya, A Kungu, JG Mati, LA Brinton, M Freedman, R Hoover, C Schairer, RG Ziegler, E Bank, R Spirta, HP Lee, MA Rooku, FE van Leeuwen, JA Schoenberg, S Graff-Iversen, R Selmer, S Atkinson, I Barne, V Beral, D Bull, T Gathani, A Goodill, J Green, C Hermon, T Key, K Pirie, G Reeve, K Shaw, TO Yang, R Collin, HC Pan, R Peto, R Ghiasvand, K Mabuchi, D Preston, SE McCann, P Hannaford, C Kay, JM Hampton, LJ Titu, A Trentham-Dietz, B Liu, YT Gao, F Jin, J-M Yuan, HY Wei, T Yun, C Zhiheng, PF Coogan, JR Palmer, L Rosenberg, EM John, Q-S Wang, M Kawai, Y Minami, I Tsuji, M Kumle, H Stalsberg, E Lund, EO Fourkala, I Jacob, U Menon, A Ryan, L Hartman, H Olsson, K Katsouyanni, A Trichopoulou, A Tzonou, KA Baltzell, A Dabancen, L Martinez, R Molina, O Sala, L Rosero-Bixby, FE Alexander, K Anderson, AR Folsom, MD Gammon, BS Hulka, R Millikan, CED Chilver, M McCredie, C Paul, DCG Skegg, GFS Spear, F Lumachi, TR Rebbeck, RA Apelo, J Baen, JR de la Cruz, B Javier, LB Lacaya, CA Ngelangel, J Cauley, for the Study of Osteoporotic Fracture, C Bain, F Schofield, V Siskind, L Bernstein, S Enger, RW Haile, A Paganini-Hill, G Ursin, AH Wu, MC Yu, M Ewertz, EA Clarke, XO Shu, W Zheng, M Ga, MJ O’Sullivan, A Kalache, TMM Farley, S Holck, O Meirik, A Fukao, X Zhou, Pirie, K, Cancer, Collaborative Group on Hormonal Factors in Breast

المصدر: Lancet, 394(10204), 1159-1168. Elsevier Science

مصطلحات موضوعية: Adult, Risk, Oncology, medicine.medical_specialty, Time Factors, menopause, Breast Neoplasms, 030204 cardiovascular system & hematology, meta-analysi, 03 medical and health sciences, breast cancer, 0302 clinical medicine, Breast cancer, ESTROGEN-PLUS-PROGESTIN, Risk Factors, Internal medicine, Epidemiology of cancer, Epidemiology, medicine, Humans, Obesity, 030212 general & internal medicine, Progesterone, Aged, Principal Component Analysis, INITIATIVE CLINICAL-TRIAL, hormone therapy, business.industry, Estrogen Replacement Therapy, Estrogens, General Medicine, Middle Aged, medicine.disease, 3. Good health, Logistic Models, POSTMENOPAUSAL WOMEN, Meta-analysis, epidemiology, Drug Therapy, Combination, Female, Menopausal hormone therapy, Progestins, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::439d0f8027a6f9d2226fb0e42b5966f1
https://cris.maastrichtuniversity.nl/en/publications/88a75911-ca7a-43e6-91a1-ba6c24758e34

المؤلفون: MC Yu, A. Dabancens, R. Apelo, Eiliv Lund, R Talamini, Suporn Koetsawang, Valerie Beral, A. O. Varma, E. A. Noonan, L. M. Kolonel, L. Schuman, Mark W. Oberle, R. J. Coates, MG Leê, TR Moller, Sarah M. Richardson, C. Wongsrichanalai, Louise A. Brinton, Giske Ursin, S Jones, Charlotte Paul, M Vessey, Herbert B. Peterson, Dcg Skegg, H. Stalsberg, G. Berry, Leslie Bernstein, L. Martinez, B. Boosiri, NS Weiss, K. Ebeling, Stephen W. Duffy, Graeme Fraser, Srp Fine, E. A. Clarke, S. B. Salazar, B Javier, H. Y. Wei, L. Piana, Monica Ferraroni, Clifford R. Kay, Robert Spirtas, A Bachelot, J-M Yuan, L B Lacaya, C. Zhiheng, Jonas Ranstam, Victor Siskind, A. Kungu, Q-S Wang, R. D. Bulbrook, Diana Bull, N. Andrieu, R Hoover, M. P. Longnecker, Annlia Paganini-Hill, Martin C. Mahoney, S. Chutivongse, CW Heath, J. G. Mati, Nicholas G. Martin, F Schofield, P. Ontiveros, Baruch Modan, M. C. Leske, C. Theetranont, B Crossley, C. Segala, R. L. Hanson, E Marbuni, S. Silpisornkosol, Gammon, HO Adami, Hoyt G. Wilson, Luis Rosero-Bixby, Chris Bain, Jack Cuzick, Håkan Olsson, W. L. Beeson, J. R. de la Cruz, Anthony B. Miller, J Deacon, D. Yeates, Philip C Hannaford, A Brêmond, Barbara S. Hulka, A. Palet, Tim Bishop, R.A. Goldbohm, Eva Negri, Gfs Spears, Philip A. Band, R Maclennan, T. G. Hislop, T Evstifeeva, T. Rohan, GD Friedman, Elaine Ron, C. Wall, Amy Nomura, Richard Peto, B. Gairard, R. Shearman, Julian Peto, Timothy J. Key, D. Kunde, Robert A. Hiatt, D. Gatei, HP Lee, P.A. van den Brandt, R. Renaud, J Cooper Booth, P Smith, R. Molina, J. Stare, N. Aristizabel, H. L. Miracle-McMahill, K. Kosmelj, I. S. Fentiman, L Jones, Rory Collins, F.E. van Leeuwen, J. L. Hayward, P. Kenya, Tmn Farley, T. Yun, M Gerber, A. Neil, R Doll, Andrew J. Coldman, De Yun Wang, C Hermon, T. Jelihovsky, FE Alexander, Howard W. Ory, N. Chantarakul, Tieng Pardthaisong, C Schairer, Richard P. Gallagher, J Baens, MA Rookus, Clewis G Reeves, O. Meirik, C. N. Taylor, Janet L. Stanford, E. Alfandary, A. L. Weinstein, JM Liff, J. Lansac, AJ McMichael, PC Nasca, R Bergstrom, Kathi Malone, A. Cuadros, J. A. Schoenberg, C. La Vecchia, M. Primic-Zakelj, Emily White, K McPherson, R. K. Ross, P. Nishan, P Jimakorn, B. Ravnihar, Moyses Szklo, Robert W. Haile, W Stewart, P. Yang, D. S. Allen, Pramuan Virutamasen, David B. Thomas, D. Rachawat, F Clavel, Malcolm C. Pike, C. J. Baines, A Morabia, C. E. D. Chilvers, H. R. Cuevas, EE Calle, Peter Boyle, Marianne Ewertz, CA Ngelangel, Janet R. Daling, O. Salas, Silvia Franceschi, Graham A. Colditz, S. Holck, Phyllis A. Wingo

المصدر: Contraception. 54(suppl3)

مصطلحات موضوعية: Oncology, Gynecology, medicine.medical_specialty, education.field_of_study, medicine.drug_class, business.industry, Population, Obstetrics and Gynecology, Cancer, medicine.disease, Breast cancer, Reproductive Medicine, Estrogen, Internal medicine, medicine, business, education, Hormone

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74f661b90eaf9fe7ce21e676ce62039
https://cris.maastrichtuniversity.nl/en/publications/539f791e-27df-4745-ac13-d9b6638622a3

المؤلفون: Mm, Gaudet, Kirchhoff T, Green T, Vijai J, Jm, Korn, Guiducci C, Av, Segrè, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Om, Sinilnikova, Stoppa-Lyonnet D, Mazoyer S, Gauthier-Villars M, Sobol H, Longy M, Frenay M, Gemo, Study Collaborators, Fbl, Hogervorst, Ma, Rookus, Jm, Collée, Hoogerbrugge N, Kep, Roozendaal, Piedmonte M, Rubinstein W, Nerenstone S, Van Le L, Sv, Blank, Caldés T, de la Hoya M, Nevanlinna H, Aittomäki K, Lazaro C, Blanco I, Arason A, Ot, Johannsson, Rb, Barkardottir, Devilee P, Oi, Olopade, Sl, Neuhausen, Wang X, Zs, Fredericksen, Peterlongo P, Manoukian S, Barile M, Viel A, Radice P, Cm, Phelan, Narod S, Rennert G, Lejbkowicz F, Flugelman A, Il, Andrulis, Glendon G, Ozcelik H, Ae, Toland, Montagna M, D'Andrea E, Friedman E, Laitman Y, Borg A, Beattie M, Sj, Ramus, Sm, Domchek, Kl, Nathanson, Rebbeck T, Ab, Spurdle, Chen X, Holland H, Em, John, Jl, Hopper, Ss, Buys, Mb, Daly, Mc, Southey, Mb, Terry, Tung N, Tv, Overeem Hansen, Fc, Nielsen, Mi, Greene, Pl, Mai, Ana Osorio, Durán M, Andres R, Benítez J, Jn, Weitzel, Garber J, Hamann U, Peock S, Cook M, Oliver C, Frost D, Platte R, Dg, Evans, Lalloo F, Eeles R, Izatt L, Walker L, Eason J, Barwell J, Ak, Godwin, Rk, Schmutzler, Wappenschmidt B, Engert S, Arnold N, Gadzicki D, Dean M, Gold B, Rj, Klein, Fj, Couch, Chenevix-Trench G, Df, Easton, Mj, Daly, Ac, Antoniou, Dm, Altshuler, Offit K

المصدر: Europe PubMed Central
PLoS Genetics
Ignacio Blanco

مصطلحات موضوعية: Genetics, Cancer Research, business.industry, Genetic variants, Correction, Biology, medicine.disease, Penetrance, Text mining, Breast cancer, medicine, business, Molecular Biology, Genetics (clinical), Ecology, Evolution, Behavior and Systematics

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d06f873f640a23b3ea7090227a8517d2
http://europepmc.org/abstract/PMC/PMC2999983

المؤلفون: Yang X; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK xy249@medschl.cam.ac.uk., Mooij TM; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Ficorella L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Andrieu N; INSERM U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Kast K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany., Singer CF; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland., van Gils CH; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Tan YY; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Adank MA; Department of Clinical Genetics, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Ausems MGEM; Devision Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands., Berthet P; Oncogénétique Département de Biopathologie, Centre François Baclesse, Caen, France., Collee MJ; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands., Cook JA; Sheffield Clinical Genetics Service, Scheffield Children's Hospital, Sheffield, UK., Eason J; Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK., Spaendonck-Zwarts KYV; Department of Human Genetics, Amsterdam University Medical Centres, Amsterdam, The Netherlands., Evans DG; The Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, UK.; Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Manchester Breast Centre, Oglesby Cancer Research Centre, The Christie, University of Manchester, Manchester, UK., Gómez García EB; Department of Clinical Genetics, Maastricht University, Maastricht, The Netherlands., Hanson H; South West Thames Regional Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK., Izatt L; Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Kemp Z; Department of Cancer Genetics, Royal Marsden Hospital, NHS Trust, London, UK., Lalloo F; Clinical Genetics Service, Manchester Centre for Genomic Medicine, Manchester University Hospitals Foundation Trust, Manchester, UK., Lasset C; Université Claude Bernard Lyon 1, Villeurbanne, France.; CNRS UMR 5558, Lyon, France.; Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France., Lesueur F; INSERM U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Musgrave H; Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Nambot S; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs, CHU de Dijon, Hôpital d'Enfants, Dijon, France.; Centre de Lutte contre le Cancer Georges François Leclerc, Dijon, France., Noguès C; Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli Calmettes, Marseille, France.; Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France., Oosterwijk JC; Department of Genetics, University of Groningen, University Medical Center, Groningen, The Netherlands., Stoppa-Lyonnet D; Institut Curie, Service de Génétique, Paris, France.; Université Paris CIté, Paris, France.; INSERM U830, Paris, France., Tischkowitz M; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Tripathi V; Clinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK., Wevers MR; Department of Clinical Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Zhao E; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., van Leeuwen FE; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schmidt MK; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Division of Molecular Pathology and Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Rookus MA; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.

مؤلفون مشاركون: EMBRACE collaborators

المصدر: Journal of medical genetics [J Med Genet] 2024 Jul 19; Vol. 61 (8), pp. 803-809. Date of Electronic Publication: 2024 Jul 19.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 2985087R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-6244 (Electronic) Linking ISSN: 00222593 NLM ISO Abbreviation: J Med Genet Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/epidemiology , BRCA2 Protein*/genetics , BRCA1 Protein*/genetics , Heterozygote* , Genetic Predisposition to Disease*, Humans ; Female ; Middle Aged ; Adult ; Prospective Studies ; Risk Factors ; Risk Assessment ; Polymorphism, Single Nucleotide/genetics

المؤلفون: Kast K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany. karin.kast@uk-koeln.de., John EM; Department of Epidemiology & Population Health and of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia., Andrieu N; INSERM U900, Paris, France.; Institut Curie, Paris, France.; Mines Paris Tech, Fontainebleau, France.; PSL Research University, Paris, France., Noguès C; Aix Marseille Université, INSERM, IRD, SESSTIM, Marseille, France.; Département d'Anticipation et de Suivi Des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France., Mouret-Fourme E; Institut Curie, Paris, France., Lasset C; Centre Léon Bérard, Lyon, France., Fricker JP; CRLCC Paul Strauss, Strasbourg, France., Berthet P; Centre François Baclesse, Caen, France., Mari V; Centre Antoine Lacassagne, Nice, France., Salle L; Oncogénétique Poitou-Charentes, Niort, France., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Ausems MGEM; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Garcia EBG; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands., van de Beek I; Department of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Wevers MR; Department of Clinical Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Evans DG; The Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, UK.; Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Manchester Breast Centre, Oglesby Cancer Research Centre, The Christie, University of Manchester, Manchester, UK., Tischkowitz M; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Lalloo F; Clinical Genetics Service, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK., Izatt L; Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Tripathi V; Clinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK., Snape K; Department of Clinical Genetics, St George's University Hospitals NHS Foundation Trust, London, UK., Musgrave H; Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Sharif S; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK., Murray J; Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK.; South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, UK.; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Colonna SV; Department of Medicine and Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, USA., Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA., Southey MC; Precision Medicine, School of Clinical Sciences at, Monash Health Monash University, Clayton, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia., de la Hoya M; Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain., Osorio A; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) and Spanish Network On Rare Diseases (CIBERER), Madrid, Spain., Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Berkova D; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland., Singer CF; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Tan Y; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Augustinsson A; Department of Oncology, Clinical Sciences in Lund, Lund University Hospital, Lund, Sweden., Rantala J; Clinical Genetics, Karolinska Institutet, Stockholm, Sweden., Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Quebec City, QC, Canada., Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany., Milne RL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Phillips KA; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia., Terry MB; Department of Epidemiology, Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Goldgar D; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, USA., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Mooij TM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, Leipzig University, Leipzig, Germany.

مؤلفون مشاركون: EMBRACE Collaborators

المصدر: Breast cancer research : BCR [Breast Cancer Res] 2023 Jun 20; Vol. 25 (1), pp. 72. Date of Electronic Publication: 2023 Jun 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA2* , Breast Neoplasms*/epidemiology , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology, Adult ; Female ; Humans ; Body Mass Index ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Risk ; Retrospective Studies ; Weight Gain/genetics ; Heterozygote ; Genetic Predisposition to Disease

المؤلفون: Figlioli G; IFOM ETS - The AIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy., Billaud A; IFOM ETS - The AIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy., Ahearn TU; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA., Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus., Becher H; University Medical Center Hamburg-Eppendorf, Institute of Medical Biometry and Epidemiology, Hamburg, Germany., Beckmann MW; University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Behrens S; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Benitez J; Spanish National Cancer Research Centre (CNIO), Human Genetics Group, Madrid, Spain.; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Bermisheva M; Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia., Blok MJ; Maastricht University Medical Center, Department of Clinical Genetics, Maastricht, the Netherlands., Bogdanova NV; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.; Hannover Medical School, Department of Radiation Oncology, Hannover, Germany.; Hannover Medical School, Gynaecology Research Unit, Hannover, Germany., Bonanni B; IEO, European Institute of Oncology IRCCS, Division of Cancer Prevention and Genetics, Milan, Italy., Burwinkel B; German Cancer Research Center (DKFZ), Molecular Epidemiology Group, C080, Heidelberg, Germany.; University of Heidelberg, Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, Heidelberg, Germany., Camp NJ; University of Utah, Department of Internal Medicine and Huntsman Cancer Institute, Salt Lake City, UT, USA., Campbell A; University of Edinburgh, Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, Edinburgh, UK.; The University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK., Castelao JE; Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Oncology and Genetics Unit, Vigo, Spain., Cessna MH; Intermountain Healthcare, Salt Lake City, UT, USA., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA., Czene K; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Devilee P; Leiden University Medical Center, Department of Pathology, Leiden, the Netherlands.; Leiden University Medical Center, Department of Human Genetics, Leiden, the Netherlands., Dörk T; Hannover Medical School, Gynaecology Research Unit, Hannover, Germany., Engel C; University of Leipzig, Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany.; University of Leipzig, LIFE - Leipzig Research Centre for Civilization Diseases, Leipzig, Germany., Eriksson M; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Fasching PA; University Hospital Erlangen, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Figueroa JD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.; The University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.; The University of Edinburgh, Cancer Research UK Edinburgh Centre, Edinburgh, UK., Gabrielson M; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Gago-Dominguez M; Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Genomic Medicine Group, International Cancer Genetics and Epidemiology Group, Santiago de Compostela, Spain.; University of California San Diego, Moores Cancer Center, La Jolla, CA, USA., García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA., González-Neira A; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain., Grassmann F; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.; Health and Medical University, Potsdam, Germany., Guénel P; INSERM, University Paris-Saclay, Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, Villejuif, France., Gündert M; German Cancer Research Center (DKFZ), Molecular Epidemiology Group, C080, Heidelberg, Germany.; University of Heidelberg, Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, Heidelberg, Germany.; Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Diabetes Research, Neuherberg, Germany., Hadjisavvas A; The Cyprus Institute of Neurology & Genetics, Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, Nicosia, Cyprus., Hahnen E; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Familial Breast and Ovarian Cancer, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Integrated Oncology (CIO), Cologne, Germany., Hall P; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.; Södersjukhuset, Department of Oncology, Stockholm, Sweden., Hamann U; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany., Harrington PA; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., He W; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Hillemanns P; Hannover Medical School, Gynaecology Research Unit, Hannover, Germany., Hollestelle A; Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands., Hooning MJ; Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands., Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany., Howell A; University of Manchester, Division of Cancer Sciences, Manchester, UK., Humphreys K; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Jager A; Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands., Jakubowska A; Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Center, Szczecin, Poland.; Pomeranian Medical University, Independent Laboratory of Molecular Biology and Genetic Diagnostics, Szczecin, Poland., Khusnutdinova EK; Institute of Biochemistry and Genetics of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.; Bashkir State University, Department of Genetics and Fundamental Medicine, Ufa, Russia., Ko YD; Department of Internal Medicine, Johanniter GmbH Bonn, Johanniter Krankenhaus, Bonn, Germany., Kristensen VN; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway., Lindblom A; Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden.; Karolinska University Hospital, Department of Clinical Genetics, Stockholm, Sweden., Lissowska J; M. Sklodowska-Curie National Research Oncology Institute, Department of Cancer Epidemiology and Prevention, Warsaw, Poland., Lubiński J; Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Center, Szczecin, Poland., Mannermaa A; University of Eastern Finland, Translational Cancer Research Area, Kuopio, Finland.; University of Eastern Finland, Institute of Clinical Medicine, Pathology and Forensic Medicine, Kuopio, Finland.; Kuopio University Hospital, Biobank of Eastern Finland, Kuopio, Finland., Manoukian S; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Unit of Medical Genetics, Department of Medical Oncology and Hematology, Milan, Italy., Margolin S; Södersjukhuset, Department of Oncology, Stockholm, Sweden.; Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden., Mavroudis D; University Hospital of Heraklion, Department of Medical Oncology, Heraklion, Greece., Newman WG; University of Manchester, Manchester Academic Health Science Centre, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.; St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester, UK., Obi N; University Medical Center Hamburg-Eppendorf, Institute of Medical Biometry and Epidemiology, Hamburg, Germany., Panayiotidis MI; The Cyprus Institute of Neurology & Genetics, Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, Nicosia, Cyprus., Rashid MU; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.; Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Department of Basic Sciences, Lahore, Pakistan., Rhenius V; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Rookus MA; The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands., Saloustros E; University Hospital of Larissa, Department of Oncology, Larissa, Greece., Sawyer EJ; King's College London, School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, London, UK., Schmutzler RK; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Familial Breast and Ovarian Cancer, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Integrated Oncology (CIO), Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Shah M; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Sironen R; University of Eastern Finland, Translational Cancer Research Area, Kuopio, Finland.; University of Eastern Finland, Institute of Clinical Medicine, Pathology and Forensic Medicine, Kuopio, Finland.; Kuopio University Hospital, Imaging Center, Department of Clinical Pathology, Kuopio, Finland., Southey MC; Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, Victoria, Australia.; The University of Melbourne, Department of Clinical Pathology, Melbourne, Victoria, Australia.; Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, Victoria, Australia., Suvanto M; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Tollenaar RAEM; Leiden University Medical Center, Department of Surgery, Leiden, the Netherlands., Tomlinson I; The University of Edinburgh, Cancer Research Centre, Edinburgh, UK., Truong T; INSERM, University Paris-Saclay, Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, Villejuif, France., van der Kolk LE; The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Family Cancer Clinic, Amsterdam, the Netherlands., van Veen EM; University of Manchester, Manchester Academic Health Science Centre, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.; St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester, UK., Wappenschmidt B; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Familial Breast and Ovarian Cancer, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Integrated Oncology (CIO), Cologne, Germany., Yang XR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA., Bolla MK; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Dennis J; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Dunning AM; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Easton DF; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Lush M; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Michailidou K; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.; The Cyprus Institute of Neurology & Genetics, Biostatistics Unit, Nicosia, Cyprus., Pharoah PDP; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Wang Q; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Adank MA; The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Family Cancer Clinic, Amsterdam, the Netherlands., Schmidt MK; The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands.; The Netherlands Cancer Institute, Division of Molecular Pathology, Amsterdam, the Netherlands., Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, Ontario, Canada.; University of Toronto, Department of Molecular Genetics, Toronto, Ontario, Canada., Chang-Claude J; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.; University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany., Nevanlinna H; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Chenevix-Trench G; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, Queensland, Australia., Evans DG; University of Manchester, Manchester Academic Health Science Centre, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.; St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester, UK., Milne RL; Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, Victoria, Australia.; Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, Victoria, Australia.; The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia., Radice P; Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Experimental Oncology, Milan, Italy., Peterlongo P; IFOM ETS - The AIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy. paolo.peterlongo@ifom.eu.

مؤلفون مشاركون: NBCS Collaborators, KConFab Investigators

المصدر: European journal of human genetics : EJHG [Eur J Hum Genet] 2023 May; Vol. 31 (5), pp. 578-587. Date of Electronic Publication: 2023 Jan 27.

نوع المنشور: Meta-Analysis; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9302235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5438 (Electronic) Linking ISSN: 10184813 NLM ISO Abbreviation: Eur J Hum Genet Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , DNA Helicases*/genetics, Humans ; Female ; Triple Negative Breast Neoplasms/genetics ; Genetic Predisposition to Disease

المؤلفون: Schrijver LH; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mooij TM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Pijpe A; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mourits MJE; Department of Gynecologic Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Andrieu N; INSERM U900, Paris, France.; Institut Curie, Paris, France.; Mines Paris Tech, Fontainebleau, France.; PSL Research University, Paris, France., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany., Goldgar D; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, USA., John EM; Department of Epidemiology & Population Health and Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Kast K; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany., Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia., Olsson H; Department of Oncology, Lund University Hospital, Lund, Sweden., Phillips KA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia., Terry MB; Department of Epidemiology, Columbia University, New York, NY, USA., Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 Apr 11; Vol. 114 (4), pp. 540-552.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/epidemiology , Breast Neoplasms*/genetics , Breast Neoplasms*/prevention & control , Endometrial Neoplasms*/epidemiology , Endometrial Neoplasms*/genetics , Endometrial Neoplasms*/prevention & control , Ovarian Neoplasms*/epidemiology , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/prevention & control, Adult ; Aged ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Contraceptives, Oral, Combined ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Heterozygote ; Humans ; Mutation ; Ovariectomy ; Risk Assessment ; Young Adult

المؤلفون: de Jonge MM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., de Kroon CD; Department of Gynaecology, Leiden University Medical Center, Leiden, the Netherlands., Jenner DJ; Department of Epidemiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Oosting J; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., de Hullu JA; Department of Gynaecology, RadboudUMC, Nijmegen, the Netherlands., Mourits MJE; Department of Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Gómez Garcia EB; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands., Ausems MGEM; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Margriet Collée J; Department of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., van Engelen K; Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., van de Beek I; Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Rookus MA; Department of Epidemiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., de Bock GH; Department of Epidemiology, University Medical Center Groningen, Groningen, the Netherlands., van Leeuwen FE; Department of Epidemiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Dekkers OM; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.

مؤلفون مشاركون: Hebon Group

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Sep 04; Vol. 113 (9), pp. 1203-1211.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/epidemiology , Breast Neoplasms*/genetics , Endometrial Neoplasms*/epidemiology , Endometrial Neoplasms*/genetics, Adult ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Cohort Studies ; Female ; Genetic Predisposition to Disease ; Germ Cells ; Heterozygote ; Humans ; Mutation

المؤلفون: Lakeman IMM; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., van den Broek AJ; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Vos JAM; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Barnes DR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Adlard J; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK., Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Arason A; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Arnold N; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.; Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany., Arun BK; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Balmaña J; Hereditary cancer Genetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, University Hospital of Vall d'Hebron, Barcelona, Spain., Barrowdale D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Benitez J; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Borg A; Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden., Caldés T; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain., Caligo MA; SOD Genetica Molecolare. University Hospital, Pisa, Italy., Chung WK; Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA., Claes KBM; Centre for Medical Genetics, Ghent University, Ghent, Belgium., Collée JM; Department of Clinical Genetics, Erasmus University Medical Center, CA, Rotterdam, The Netherlands., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA., Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Dhawan M; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, USA., Domchek SM; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Eeles R; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Evans DG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Feliubadaló L; Hereditary Cancer Program, ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel., Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Ganz PA; Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Centre, UCLA, Los Angeles, CA, USA., Garber J; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA., Gayther SA; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core. Cedars-Sinai Medical Center, Los Angeles, CA, USA., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA., Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Hake CR; Waukesha Memorial Hospital-Pro Health Care, Waukesha, WI, USA., Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hogervorst FBL; Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia., Hulick PJ; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.; The University of Chicago Pritzker School of Medicine, Chicago, IL, USA., Imyanitov EN; N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Izatt L; Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland., James PA; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Janavicius R; Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.; State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania., Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark., Jiao Y; Genetic Epidemiology of Cancer team, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France., John EM; Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Joseph V; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Karlan BY; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA., Kets CM; Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Konstantopoulou I; Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece., Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.; Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.; Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong., Legrand C; Département de Génétique, CHU de Grenoble, Grenoble, France., Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Lesueur F; Genetic Epidemiology of Cancer team, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France., Loud JT; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., McGuffog L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Miller A; NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA., Gomes DM; Service de Biologie de la reproduction, Cytogénétique et Génétique Médicale, CHI Poissy-Saint Germain, Poissy, France., Montagna M; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Mouret-Fourme E; Service de Génétique, Institut Curie, Paris, France., Nathanson KL; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Yie JNY; Cancer Genetics Service, National Cancer Centre, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Olopade OI; Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA., Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea., Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Peterlongo P; Genome Diagnostics Program, IFOM-the FIRC Institute of Molecular Oncology, Milan, Italy., Piedmonte M; NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Rantala J; Clinical Genetics, Karolinska Institutet, Stockholm, Sweden., Rennert G; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel., Risch HA; Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA., Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Sharma P; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, KS, USA., Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, QC, Canada., Singer CF; Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Stadler Z; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Paris, France.; Department of Tumour Biology, INSERM U830, Paris, France.; Université Paris Descartes, Paris, France., Sutter C; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany., Tan YY; Dept of OB/GYN, Medical University of Vienna, Vienna, Austria., Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.; Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal., Teo SH; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Teulé A; Hereditary Cancer Program, ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark., Thull DL; Department of Medicine, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Tischkowitz M; Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, QC, Canada.; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge. Vol Box 134, Level 6 Addenbrooke's Treatment Centre, Addenbrooke's Hosptital, Cambridge, UK., Toland AE; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA., Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., van Rensburg EJ; Department of Genetics, University of Pretoria, Arcadia, South Africa., Vega A; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain., Wappenschmidt B; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Devilee P; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Bernstein JL; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Offit K; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Rookus MA; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands., Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Robson M; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Schmidt MK; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. mk.schmidt@nki.nl.; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. mk.schmidt@nki.nl.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands. mk.schmidt@nki.nl.

مؤلفون مشاركون: GEMO Study Collaborators, EMBRACE Collaborators, OCGN Investigators, HEBON Investigators, KconFab Investigators

المصدر: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2021 Sep; Vol. 23 (9), pp. 1726-1737. Date of Electronic Publication: 2021 Jun 10.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9815831 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0366 (Electronic) Linking ISSN: 10983600 NLM ISO Abbreviation: Genet Med Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/diagnosis , Breast Neoplasms*/epidemiology , Breast Neoplasms*/genetics, Adult ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Female ; Genetic Predisposition to Disease ; Heterozygote ; Humans ; Mutation ; Retrospective Studies ; Risk Factors

المؤلفون: Schrijver LH; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Olsson H; Department of Oncology, Lund University Hospital, Lund, Sweden., Mooij TM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Roos-Blom MJ; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Azarang L; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Adlard J; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom., Ahmed M; North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom., Barrowdale D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Davidson R; Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, United Kingdom., Donaldson A; Department of Clinical Genetics, St. Michael's Hospital, Bristol, United Kingdom., Eeles R; Oncogenetics Team, The Institute of Cancer Research, London, United Kingdom., Evans DG; Division of Evolution and Genomic Sciences, Department of Genomic Medicine, Manchester Academic Health Sciences Centre, Manchester University, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom., Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Henderson A; Centre for Life, Institute of Genetic Medicine, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom., Izatt L; Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Ong KR; West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Edgbaston, Birmingham, United Kingdom., Bonadona V; Université Claude Bernard Lyon 1, Villeurbanne, France; Centre National de la Recherche Scientifique, Unités Mixtes de Recherche, Lyon, France; Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France., Coupier I; Centre Hospitalier Universitaire de Montpellier, Hôpital Arnaud de Villeneuve, Montpellier, France; Service de Génétique médicale et Oncogénétique, Montpellier, France; Institut National de la Santé et de la Recherche Médicale, Centre de Recherche en Cancérologie de Marseille Val d'Aurel, Montpellier, France., Faivre L; Genomic and Immunotherapy Medical Institute, Hôpital d'Enfants, Centre Hospitalier Universitaire de Dijon, Dijon, France; Unité d'Oncogénétique, Centre de Lutte Contre le Cancer Georges François Leclerc, Dijon, France., Fricker JP; Unité d' Oncogénétique, Centre Paul Strauss, Strasbourg, France., Gesta P; Service d'Oncogénétique Régional Poitou-Charentes, Centre Hospitalier Georges Renon, Niort, France., van Engelen K; Department of Clinical Genetics, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Jager A; Department of Medical Oncology, Family Cancer Clinic, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Menko FH; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mourits MJE; Department of Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Singer CF; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Tan YY; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Navratilova M; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Schmutzler RK; Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany., Ellberg C; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, København, Denmark., Caldes T; Molecular Oncology Laboratory, Hospital Clinico San Carlos, Instituto de Investigación Hospital Clínico San Carlos, Centro de Investigación Biomédica en Red de Cáncer, Martin Lagos, Madrid, Spain., Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, Québec, Canada., Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland., Rantala J; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Osorio A; Human Genetics Group, Centro Nacional De Investigaciones Oncologicas, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain., Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia., Phillips KA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia; Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Parkville, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia., Milne RL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia., Beth Terry M; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY., Noguès C; Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France; Institut National de la Santé et de la Recherche Médicale, Institut de Recherche pour le Développement, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, Aix-Marseille University, Marseille, France., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany., Kast K; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany., Goldgar DE; Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Andrieu N; Institut National de la Santé et de la Recherche Médicale, Paris, France; Institut Curie, Paris, France; Mines ParisTech, Fontainebleau, Paris, France; Paris Sciences et Lettres University, Paris, France., Rookus MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: m.rookus@nki.nl.

مؤلفون مشاركون: Epidemiological Study of Familial Breast Cancer, Gene Etude Prospective Sein Ovaire Sein, Hereditary Breast and Ovarian Cancer Research Group Netherlands, and International BRCA1/2 Carrier Cohort Study

المصدر: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2021 Jul; Vol. 225 (1), pp. 51.e1-51.e17. Date of Electronic Publication: 2021 Jan 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0370476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6868 (Electronic) Linking ISSN: 00029378 NLM ISO Abbreviation: Am J Obstet Gynecol Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Contraceptives, Oral/*administration & dosage , Ovarian Neoplasms/*genetics , Ovarian Neoplasms/*prevention & control, Adult ; Cohort Studies ; Europe/epidemiology ; Female ; Follow-Up Studies ; Genetic Predisposition to Disease ; Humans ; Middle Aged ; Ovarian Neoplasms/epidemiology ; Proportional Hazards Models ; Retrospective Studies